Retatrutides GLP-1, GIP, and Glucagon Receptor Profiles Do Not Scale Equally Retatrutide engages three receptors that scale at different rates and do different jobs
In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group
But what if there was a tiny peptide that flips the script from "manage the pain" to "heal the pain"
However, this represents an off-label use without established protocols or evidence base
I feel more alert and focused throughout the day, and Im even sleeping better at night. I struggled with depression for years, but since starting B-12 injections, Ive noticed a huge improvement in my mood and overall wellbeing
